Kintor Pharma Moves Board Meeting to 30 March 2026

Bulletin Express

Yesterday

Kintor Pharmaceutical Limited announced on 23 March 2026 that its board meeting—initially set for 26 March 2026—has been rescheduled to 30 March 2026.

The meeting’s agenda remains unchanged and will focus on reviewing and approving the company’s annual results for the financial year ended 31 December 2025, together with the related results announcement.

According to the filing, the postponement was prompted by directors’ scheduling considerations.

The board is chaired by Dr. Youzhi Tong, who also serves as Executive Director and Chief Executive Officer. Other directors include Executive Director Dr. Xiang Ni; Non-executive Directors Mr. Yunfei Chen and Ms. Geqi Wei; and Independent Non-executive Directors Dr. Michael Min Xu, Mr. Wallace Wai Yim Yeung and Prof. Liang Tong.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1129490197"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1129490197\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1129490197?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-23 17:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129490197","market":"hk","top_or_hot":-1,"title":"Kintor Pharma Moves Board Meeting to 30 March 2026","media":"Bulletin Express","content":"<p>Kintor Pharmaceutical Limited announced on 23 March 2026 that its board meeting—initially set for 26 March 2026—has been rescheduled to 30 March 2026.</p>\n<p>The meeting’s agenda remains unchanged and will focus on reviewing and approving the company’s annual results for the financial year ended 31 December 2025, together with the related results announcement.</p>\n<p>According to the filing, the postponement was prompted by directors’ scheduling considerations.</p>\n<p>The board is chaired by Dr. Youzhi Tong, who also serves as Executive Director and Chief Executive Officer. Other directors include Executive Director Dr. Xiang Ni; Non-executive Directors Mr. Yunfei Chen and Ms. Geqi Wei; and Independent Non-executive Directors Dr. Michael Min Xu, Mr. Wallace Wai Yim Yeung and Prof. Liang Tong.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kintor Pharma Moves Board Meeting to 30 March 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKintor Pharma Moves Board Meeting to 30 March 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-23 17:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Kintor Pharmaceutical Limited announced on 23 March 2026 that its board meeting—initially set for 26 March 2026—has been rescheduled to 30 March 2026.</p>\n<p>The meeting’s agenda remains unchanged and will focus on reviewing and approving the company’s annual results for the financial year ended 31 December 2025, together with the related results announcement.</p>\n<p>According to the filing, the postponement was prompted by directors’ scheduling considerations.</p>\n<p>The board is chaired by Dr. Youzhi Tong, who also serves as Executive Director and Chief Executive Officer. Other directors include Executive Director Dr. Xiang Ni; Non-executive Directors Mr. Yunfei Chen and Ms. Geqi Wei; and Independent Non-executive Directors Dr. Michael Min Xu, Mr. Wallace Wai Yim Yeung and Prof. Liang Tong.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09939","symbol_name":"开拓药业-B","start_time":0,"source_url":"","article_id":"1129490197","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129490197","pubTimestamp":1774258885,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Kintor Pharmaceutical Limited announced on 23 March 2026 that its board meeting—initially set for 26 March 2026—has been rescheduled to 30 March 2026. The meeting’s agenda remains unchanged and will...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09939":"开拓药业-B"},"translate_title":"开拓药业将董事会会议推迟至2026年3月30日","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09939":1},"content_text":"Kintor Pharmaceutical Limited announced on 23 March 2026 that its board meeting—initially set for 26 March 2026—has been rescheduled to 30 March 2026.\nThe meeting’s agenda remains unchanged and will focus on reviewing and approving the company’s annual results for the financial year ended 31 December 2025, together with the related results announcement.\nAccording to the filing, the postponement was prompted by directors’ scheduling considerations.\nThe board is chaired by Dr. Youzhi Tong, who also serves as Executive Director and Chief Executive Officer. Other directors include Executive Director Dr. Xiang Ni; Non-executive Directors Mr. Yunfei Chen and Ms. Geqi Wei; and Independent Non-executive Directors Dr. Michael Min Xu, Mr. Wallace Wai Yim Yeung and Prof. Liang Tong.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}